Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

33 results
Display

Somatostatin Receptor

Kim E, Sohn S, Lee M, Park H, Jung J, Park S

  • KMID: 2200376
  • J Korean Soc Endocrinol.
  • 2003 Aug;18(4):342-355.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Somatostatin Receptor Scintigraphy

Bae SK

  • KMID: 1556299
  • Korean J Nucl Med.
  • 1999 Feb;33(1):11-27.
Peptide imaging is a new diagnostic modality in nuclear medicine. 111In-pentetreotide (OctreoscanR) is the first commercially available peptide radiopharmaceutical. This review article presents the RESULTS of previous studies using 111In-pentetreotide...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Zollinger-Ellison Syndrome with Gastrinoma Localized by 111In-Pentetreotide Scan

Jeong HJ, Ryu JS, Kim JS, Moon DH, Jung HY, Ha HK, Lee HK

  • KMID: 2038082
  • Korean J Nucl Med.
  • 1999 Dec;33(6):537-542.
In patient with Zollinger-Ellison syndrome, it is difficult to localize gastrinoma because the tumor is frequently small and multiple. However, accurate localization of the tumor is important for the treatment....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Somatostatin Receptors in Lung Cancer: From Function to Molecular Imaging and Therapeutics

Callison J, Walker RC, Massion PP

Lung cancer is a deadly disease that is difficult to diagnose and even more difficult to treat effectively. Many pathways are known to affect tumor growth, and targeting these pathways...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Review of Radionuclide Treatment for Neuroendocrine Tumors

Jeong HJ

  • KMID: 2313018
  • Nucl Med Mol Imaging.
  • 2006 Apr;40(2):90-95.
Neuroendocrine tumors (NETs) consist of a heterogeneous group of tumors that are able to uptake neuroamine and/or specific receptors, such as somatostatin receptors, which can play important roles of the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Immunoreactivity of Somatostatin Receptor Subtype 2 in Dorsal Root Ganglia in the Rat

Noh KC, Chung YK, Yoo JH, Park JS, Lee JD, Kang MC, Won MH, Kang TC, Park SK

  • KMID: 2106037
  • J Korean Orthop Assoc.
  • 2004 Feb;39(1):88-93.
PURPOSE: Somatostatin has been suggested to play a role in the transmission of neurotransmitters and in the modulation of pain. Of the different subtypes of somatostatin receptors 2, sstr2A and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Lu-177-Based Peptide Receptor Radionuclide Therapy for Advanced Neuroendocrine Tumors

Kim K, Kim SJ

Peptide receptor radionuclide therapy (PRRT) is a systemic cytotoxic radiation therapy using a compound of β-emitting radionuclide chelated to a peptide for the treatment of tumor with overexpressed specific cell...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Differential Expression of Somatostatin Receptor Subtype 2 in Dorsal Root Ganglia after Ischemic Injury in the Rat

Noh KC, Chung YK, Yoo JH, Jang WS, Lee JD, Won MH

  • KMID: 1901405
  • J Korean Orthop Assoc.
  • 2004 Dec;39(7):736-744.
PURPOSE: The somatostatin has been suggested to play a role in the transmission of neurotransmitters and the modulation of pain. Therefore, this study was carried out to investigate the spatial...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Neuroendocrine Regulation of Growth Hormone Secretion

Park S

  • KMID: 2192845
  • J Korean Soc Pediatr Endocrinol.
  • 2010 Dec;15(3):151-156.
The regulation of growth hormone (GH) secretion is, to a larger extent, controlled by three hypothalamic hormones: GH-releasing hormone (GHRH), somatostatin, and ghrelin. Each binds to G protein-linked membrane receptors...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Significance of Protein Expression of Cyclooxygenase-2 and Somatostatin Receptors in Gastroenteropancreatic Neuroendocrine Tumors

Kim HS, Lee HS, Kim WH

  • KMID: 2167556
  • Cancer Res Treat.
  • 2011 Sep;43(3):181-188.
PURPOSE: This study was undertaken to evaluate the significance of cyclooxygenase-2 (COX2) overexpression and the expression of somatostatin receptor (SSTR) subtypes in gastroenteropancreatic neuroendocrine tumors (GEP-NETs). MATERIALS AND METHODS: Two hundred...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Ga-68 Somatostatin Receptor PET/CT in von Hippel-Lindau Disease

Oh JR, Kulkarni H, Carreras C, Schalch G, Min JJ, Baum RP

  • KMID: 2052010
  • Nucl Med Mol Imaging.
  • 2012 Jun;46(2):129-133.
Von Hippel-Lindau (VHL) disease is a dominantly inherited familial cancer syndrome with a variety of benign and malignant tumors such as retinal and central nervous system hemangioblastomas, endolymphatic sac tumors,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Therapeutic Effect of a Novel Chimeric Molecule Targeting Both Somatostatin and Dopamine Receptors on Growth Hormone-Secreting Pituitary Adenomas

Kim J, Oh JH, Harlem H, Culler MD, Ku CR, Lee EJ

BACKGROUND: Acromegaly is a rare disease primarily caused by growth hormone (GH)-secreting pituitary adenomas, and its treatment is costly. Moreover, some patients are unresponsive to treatment. Hence, there are increasing...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
SSTR2A Protein Expression in Neuroendocrine Neoplasms of the Colorectum

Kim YE, Lee J, Park YS, Kim KM

BACKGROUND: Expression studies of somatostatin receptor type 2A (SSTR2A) in neuroendocrine neoplasms (NENs) led to the development of clinically relevant diagnostic and therapeutic strategies. However, most of these strategies used...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of Gs alpha Gene Mutation on the Expression of the Rat Somatostatin Receptor Gene

Yang IM, Park SJ, Jhang HG, Lee GJ, Oh SJ, Kim SW, Kim JW, Kim YS, Choi YK

  • KMID: 2199560
  • J Korean Soc Endocrinol.
  • 1999 Dec;14(4):657-666.
BACKGROUND: The growth hormone (GH)-secreting pituitary adenoma with mutation of Gs alpha gene (gsp oncogene) is known to show a higher response to somatostatin. The mechanism for the higher response...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Modulation of Pituitary Somatostatin Receptor Subtype (sst1-5) mRNA Levels by Growth Hormone (GH) -Releasing Hormone in Purified Somatotropes

Park S, Park H, Lee M, Sohn S, Kim E, Jung J, Frohman LA, Kineman RD

  • KMID: 2285276
  • Korean J Physiol Pharmacol.
  • 2003 Apr;7(2):79-84.
We have previously reported that expression of the somatostatin receptor subtypes, sst1-5, is differentially regulated by growth hormone (GH) -releasing hormone (GHRH) and forskolin (FSK), in vitro. GHRH binds to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Two cases of 111Indium Pentetreotide Scan for the Pre- and Post-Operative Evaluation of Localization and Metastasis in Medullary Thyroid Carcinoma

Chung JH, Kim KW, Ahn KJ, Min YK, Lee MS, Lee MK, Kim KA, Kim YS, Koh EM

  • KMID: 2461608
  • J Korean Soc Endocrinol.
  • 1996 Mar;11(1):85-92.
Medullary carcinoma of the thyroid gland(MTC) constitutes approximatesly 3% to 10% of all malignant thyroid tumors. It appears in both familial and sporadic forms. Metastases are frequently present at diagnosis...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Changes in Somatostatin Receptor mRNA Levels by G Protein Mutation in GH3 Cells Which Show Responsiveness to Growth Hormone-Releasing Hormone

Kim EH, Sohn SJ, Lee MA, Seo SH, Ju SH, Lee D, Chung HJ, Jung JC, Park SJ

BACKGROUNDS: GH3 cells lack growth hormone(GH)-releasing hormone(GHRH) receptors. In this study, GH3 cells permanently transfected with human GHRH receptor cDNA(GH3-GHRHR cells), were established in order to examine the effects of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Neuroendocrine Tumors

Park YS

  • KMID: 2267784
  • Korean J Med.
  • 2013 Oct;85(4):354-356.
Neuroendocrine tumors (NETs) are rare. However, several data showed the incidence is increased in the past 30 years. NETs can be both functional and non-functional, and may be undetected for...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Gene Expression of Somatostatin Receptor Subtype 2 and 5 in GH-Secreting Pituitary Adenomas

Kim SW, Kim JW, Kim YS, Choi YK, Park SJ, Yang IM, Woo JT, Kim KK

  • KMID: 2331077
  • J Korean Soc Endocrinol.
  • 1997 Dec;12(4):508-517.
BACKGROUND: SSTR2 and SSTR5 are most frequently observed in GH-secreting pituitary tumors, and SSTR5 is believed to be more specific to mammosomatotroph lineage. Octreotide binds with high affinity to those...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Incidental Detection of Parathyroid Adenoma on Somatostatin Receptor PET/CT and Incremental Role of ¹⁸F-Fluorocholine PET/CT in MEN1 Syndrome

Arora S, Damle NA, Passah A, Yadav MP, Ballal S, Aggarwal V, Gupta Y, Kumar P, Tripathi M, Bal C

Multiple endocrine neoplasia type 1 (MEN1) syndrome is characterized by combined occurrence of tumors of endocrine glands including the parathyroid, the pancreatic islet cells, and the anterior pituitary gland. Parathyroid...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr